Nong Xu
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 27, 2024
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death-1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105-204).Yulong Zheng, Jianqing Zhu, Jianping Xiong
|Oct 03, 2023
The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer.Mingyu Wan, Yongfeng Ding, Xiaolu Ma
|Nov 24, 2022
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy.Xiaolu Ma, Yongfeng Ding, Jiong Qian
|Oct 18, 2020
Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study.Haiping Jiang, Yulong Zheng, Jiong Qian
|Oct 02, 2019
90-gene signature assay for tissue origin diagnosis of brain metastases.Yulong Zheng, Yongfeng Ding, Qifeng Wang
Pageof 1
